Program
NBP608
A development code. Also written as “NBP608 (Mid Potency)” and “NBP608 (Low Potency)”.
Its studies are mostly in Chickenpox · Herpes Zoster, led by SK Chemicals.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| SK Chemicals | 51 open or running | phase 3since Apr 11, 2017 | Apr 11, 2017 | Feb 13, 2027phase 3 · NCT07415252 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 11, 2017First study: phase 2 study in ChickenpoxFirst studyNCT03114982 · 152 enrolled · Philippines
- Apr 11, 20173 phase 3 studiesNCT03114943, NCT03120364, NCT03116594
- Jan 27, 2026Phase 3 study in ChickenpoxNCT07415252 · 780 planned · Honduras, Philippines, South Korea and more
Ahead
- Feb 13, 2027Primary completion: phase 3 study in ChickenpoxNCT07415252
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07415252Chickenpox · Honduras, Philippines, South Korea and more | 3 | Recruiting | Feb 13, 2027 | 780 |
| NCT03120364Herpes Zoster · Korea, Republic of | 3 | Completed | Dec 16, 2015 | 824 |
| NCT03116594Herpes Zoster · Korea, Republic of | 3 | Completed | Apr 8, 2014 | 675 |
| NCT03114982Chickenpox · Philippines | 2 | Completed | Jul 2016 | 152 |
| NCT03114943Chickenpox · Philippines | 3 | Completed | Jun 28, 2017 | 516 |
How it is read
Names in the registry
- “NBP608”, 4 entries
- “NBP608 (Mid Potency)”, 1 entry
- “NBP608 (Low Potency)”, 1 entry
Codes read as this program: NBP608.
Conditions, from the studies’ own filings
- Chickenpox, 3 studies
- Herpes Zoster, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.